Siguldas Ciltslietu Un Maksligas Apseklosanas Stacija (SCM1R) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
21 Aug, 2025Executive summary
Leading producer of breeding bull semen and major supplier in Latvia, with milk testing as a secondary activity.
Net turnover for the first six months of 2025 reached €956.2k, up 24.5% year-over-year.
Profit before tax was €57.7k, down 6% compared to the same period last year.
Genetics sector contributed 77% and milk testing 18.1% to net turnover.
No major events or significant risks impacted the period.
Financial highlights
Net sales: €956,178 (2025 H1) vs €768,297 (2024 H1).
Profit after tax: €57,671 (2025 H1) vs €61,359 (2024 H1).
Earnings per share: €0.137 (2025 H1) vs €0.145 (2024 H1).
Cash at period end: €67,958 (2025 H1) vs €82,385 (2024 YE).
Shareholders' equity: €1,949,274 (2025 H1) vs €1,891,603 (2024 YE).
Outlook and guidance
Focus on expanding product and service volumes through increased operational efficiency.
Latest events from Siguldas Ciltslietu Un Maksligas Apseklosanas Stacija
- Net sales, profit, and EPS rose year-over-year, with improved equity and cash flow.SCM1R
Q3 202520 Nov 2025 - Net sales rose 6% but net profit and EPS declined for the nine months of 2024.SCM1R
Q3 202413 Jun 2025 - Net turnover up 1% to €768.3k, but profit before tax down 27.6% to €61.4k.SCM1R
Q2 202413 Jun 2025 - 2024 net profit rose 23.5% to €80.8k, driven by genetics sales growth and stable operations.SCM1R
Q4 20249 Jun 2025 - Net sales up 24% and net profit increased, but operating cash flow turned negative.SCM1R
Q1 20256 Jun 2025